Overcoming Therapeutic Inertia
Are you an inertia buster?
Test yourself now!
Take the Overcoming Therapeutic Inertia Self-Assessment
Introducing the OTI Initiative
Despite the approval of more than 40 new diabetes treatment options since 2005, as well as advancements in guidelines and treatment algorithms, we still haven’t been able to make a meaningful difference in improving glycemic control in people with type 2 diabetes. In fact, between 1999 and 2014 the percentage of diabetes patients with an A1C over 9% actually increased. This phenomenon is known as therapeutic inertia—delay or inaction to initiate or intensify therapy when glycemic treatment goals have not been met.
Through the Overcoming Therapeutic Inertia (OTI) initiative, the American Diabetes Association (ADA) is doing our part in creating a paradigm shift in the care of type 2 diabetes, advancing the latest thought-leadership in the category and developing purposeful practice resources and tools.
We are working across the entire health continuum to help physicians, nurse practitioners, physician assistants, pharmacists, dietitians, and diabetes educators more effectively partner with their patients to implement the most effective care strategies for proper glycemic control.
Our Strategy
All strategies in the Overcoming Therapeutic Inertia Initiative aim to either:
Drive Timely Treatment Optimization
Improve Care Plan Adherence
ADA’s Overcoming Therapeutic Inertia initiative is supported by:
Strategic Sponsors
Supporting Sponsors
